SCHEMBL9332383

SCHEMBL9332383

CCCCCCCN(CCCCCSn1cnc2cncnc21)C(=O)Nc1ccc(F)cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9335182 0.80 — —
SCHEMBL10923934 0.75 FDPS (0.38) —
SCHEMBL9152529 0.73 SOAT1 (0.67) —
SCHEMBL9157883 0.72 SOAT1 (0.66) —
SCHEMBL9159545 0.71 — —
SCHEMBL9335674 0.71 ACAT1 (0.61) —
SCHEMBL27535766 0.71 FDPS (0.40) —
SCHEMBL9257327 0.70 SOAT1 (0.86) —
SCHEMBL10587602 0.70 SOAT1 (0.86) —
SCHEMBL9335141 0.70 ACAT1 (0.60) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5290801-A Anticholesterol or antilipemic agents THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-03-01 — — US disclosed
Send feedback